Narayan Prabhu
Fortune : 2 045 $ au 31/05/2026
Fortune : 2 045 $ au 31/05/2026
Narayan Prabhu is currently Chief Financial Officer at Reviva Pharmaceuticals Holdings, Inc. since 2020.
Formerly, Mr. Prabhu was Controller at Cisco Systems, Inc. from 2009 to 2014 and Chief Financial Officer at Sony Biotechnology, Inc. from 2014 to 2019.
Education includes an MBA from Haas School of Business and an undergraduate degree from Kelley School of Business.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 25/03/2026 | 5 000 ( 0,04% ) | 2 045 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| REVIVA PHARMACEUTICALS HOLDINGS, INC. | Directeur Financier/CFO | 14/12/2020 |
| Sociétés | Poste | Fin |
|---|---|---|
Sony Biotechnology, Inc.
Sony Biotechnology, Inc. BiotechnologyHealth Technology Manufactures life science technology products | Directeur Financier/CFO | 01/04/2019 |
| CISCO SYSTEMS, INC. | Comptroller/Controller/Auditor | 01/10/2014 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 5 |
|---|---|
Cisco Systems, Inc.
Cisco Systems, Inc. Telecommunications EquipmentElectronic Technology Designs and sells networking, security, collaboration, cloud management hardware & applications to securely connect industries and communities | Electronic Technology |
Sony Biotechnology, Inc.
Sony Biotechnology, Inc. BiotechnologyHealth Technology Manufactures life science technology products | Health Technology |
Haas School of Business
Haas School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kelley School of Business
Kelley School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Reviva Pharmaceuticals Holdings, Inc.
Reviva Pharmaceuticals Holdings, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for central nervous system, cardio vascular, metabolic and inflammatory diseases | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national